POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
批准号:
6275610
负责人:
SRINIVASA N. RAJA
金额:
$2.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30
关键词:
amitriptyline analgesia chronic pain clinical research clinical trials comorbidity depression drug screening /evaluation genital herpes human subject human therapy evaluation interview medical complication morphine outcomes research pain threshold patient care management sensory mechanism shingles skin hypersensitivity
中文摘要
这项研究的目的是确定两种方法的有效性
药物、三环抗抑郁药(TCA)和阿片类药物
治疗带状疱疹后遗神经痛的安慰剂。具体目标
是比较阿片类药物和TCA与安慰剂对疼痛的影响,
改变了皮肤的敏感性,以及情感和认知功能。在……里面
此外,这项研究将确定精神病患者的存在是否
发病率,尤其是抑郁症,预示着治疗的结果。
使用阿片类药物三氯乙酸和安慰剂。
我们已经研究了持续的疼痛、脑部疾病的改变
对机械和热刺激的热敏感性和痛觉异常
PHN患者确定外周和/或中枢的作用
机制,在PHN中。持续的疼痛评级是使用口头的
比分(0-10)。在受影响的部位内进行了感官测试,
以及相应的对侧正常部位。这一地区
用棉签标记机械性异位痛感和疼痛,由
机械刺激(软毛刷、黄铜探头、冯·弗雷头发)
在1-10分的口头评分上。温度阈值为温暖、寒冷、
热痛和冷痛是使用Peltier设备和
改良Marstock术式。
迄今为止,59名患者(33名女性,26名男性)患有3-216个月的PHN
持续时间(中位数为19个月)已被研究。的平均评级
持续性疼痛为7.3±2(M+SD)。大多数患者(80%)有
由动态(毛刷)、静态(黄铜探头)或点状(von
Frey)机械刺激(Z>;5.01,p<;.0001)。没有重大意义
观察到持续疼痛的强度和
机械性超感痛症。作为一个群体,患者们展示了
对冷和热的感觉减退,对热痛的减痛
和冰冷的疼痛。在正在进行的研究中没有显著的相关性
疼痛强度和感觉变化的程度(在
未受影响和受影响的部位)处于热、冷、热疼痛和冷疼痛中
检测阈值。因此,初级传入输入在这一过程中所起的作用
PHN的发病机制尚不清楚。存在超常痛觉/痛觉过敏
对机械刺激,但相对没有痛觉过敏
这组患者中大多数患者的热刺激表明,中枢
PHN的敏感化并不适用于所有的感觉形式。
据观察,慢性疼痛的患者有很高的发病率
精神疾病。对于这些是否存在争议
病症与慢性疼痛或仅仅是
持续遭受慢性身体症状的折磨。患者已完成
关于重度抑郁、心境恶劣的结构化访谈(DIS-III-A)
精神障碍、广泛性焦虑障碍和躯体化障碍
完成了SCL-90-R的躯体化和焦虑子量表。我们的
在PHN患者中的结果与现有文献一致。
PHN患者与慢性心绞痛患者的比较
疼痛的身体症状也报告了更多的抑郁症
症状以及其他医学上无法解释的身体症状。这些
研究结果表明,抑郁和更高水平的躯体焦点是
更多的继发性并发症经历慢性症状和
与慢性疼痛有着独特的联系。
英文摘要
The purpose of this research is to determine the effectiveness of two
medications, tricyclic antitidepressants (TCA) and opioids, compared to
a placebo in the treatment of postherpetic neuralgia. The specific aims
are to compare the effects of opioids and TCA against placebo on pain,
altered skin sensitivity, and affective and cognitive function. In
addition, the study will determine if the presence of psychiatric co-
morbidity, particularly depression, predicts the outcome of treatment
with opioids, TCA, and placebo.
We have studied the relationships between ongoing pain, alterations in
thermal sensibility, and allodynia to mechanical and thermal stimuli of
patients with, PHN to determine the role of peripheral and/or central
mechanisms, in PHN. Ongoing pain ratings were obtained using a verbal
score (0-10). Sensory tests were performed within the affected site,
and the corresponding, contralateral, normal site. The area of
mechanical allodynia was mapped with a cotton swab and pain, evoked by
mechanical stimuli (soft hair brush, brass probe, von Frey hairs) was
rated on a verbal scale of 1-10. Thermal thresholds to warm, cold,
heat pain, and cold pain were determined using a Peltier device and a
modified Marstock technique.
To date, fifty-nine patients (33 F, 26 M) with PHN of 3-216 months
duration (median = 19 months) have been studied. The average rating of
ongoing pain was 7.3 + 2 (M + SD). The majority of patients (80%) had
allodynia to dynamic (hair brush), static (brass probe) or punctate (von
Frey) mechanical stimuli (Z > 5.01, p<.0001). No significant
correlation was observed between the intensity of ongoing pain and
mechanical allodynia. As a group, the patients demonstrated
hypoesthesia to cold and warm detection, and hypoalgesia to heat pain
and cold pain. There were no significant correlations between ongoing
pain intensity and the degree of sensory alterations (between the
unaffected and affected sites) in warm, cold, heat pain, and cold pain
detection thresholds. Hence, the role of primary afferent input in tlie
mechanism of PHN is uncertain. The presence of allodynia/hyperalgesia
to mechanical stimuli, but the relative absence of hyperalgesia to
thermal stimuli in most patients in this group suggests that central
sensitization in PHN is not generalized for all modalities of sensation.
It has been observed that patients with chronic pain have high rates of
psychiatric conditions. Controversy has existed as to whether these
conditions are uniquely related to chronic pain or simply the result of
ongoing suffering from a chronic physical symptom. Patients completed
a structured interview (DIS-III-A) for Major Depression, Dysthymic
Disorder, Generalized Anxiety Disorder and Somatization Disorder and
completed the Somatization and Anxiety subscales of the SCL-90-R. Our
results in PHN patients are consistent with the existing literature.
PHN patients compared to patients with chronic and distressing but non-
pain physical symptoms also reported higher numbers of depression
symptoms as well as other medically unexplained physical symptoms. These
findings suggest that depression and higher levels of somatic focus are
more than secondary complications of experiencing chronic symptoms and
are uniquely related to chronic pain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post-Amp Pain
-
批准号:7044588
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2003
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6354092
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2000
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6202103
-
项目类别:
-
资助金额:$26.21万
-
财政年份:1999
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6108824
-
项目类别:
-
资助金额:$26.21万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6297539
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
TREATMENT OF NEUROPATHIC PAIN
-
批准号:6112491
-
项目类别:
-
资助金额:$25.35万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6297552
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6218263
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6218286
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6114352
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6114375
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6241347
-
项目类别:
-
资助金额:$26.24万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
TREATMENT OF NEUROPATHIC PAIN
-
批准号:6243789
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
TRICYCLIC ANTIDEPRESSANTS AND OPIOIDS IN POSTHERPETIC NEURALGIA MANAGEMENT
-
批准号:6245387
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6275587
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
INJURY-INDUCES PAIN-- CHEMICAL MODULATION OF NOCICEPTORS
-
批准号:6393422
-
项目类别:
-
资助金额:$32.72万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
INJURY-INDUCES PAIN-- CHEMICAL MODULATION OF NOCICEPTORS
-
批准号:6539673
-
项目类别:
-
资助金额:$32.7万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
INJURY INDUCED PAIN--CHEMICAL MODULATION OF NOCICEPTORS
-
批准号:2891727
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
Injury-Induced Pain: Chemical Modulation of Nociceptors
-
批准号:7388976
-
项目类别:
-
资助金额:$30.86万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
Injury-Induced Pain: Chemical Modulation of Nociceptors
-
批准号:7778283
-
项目类别:
-
资助金额:$30.54万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
海外基金